Physician Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Physician Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.94K	Buy	617 +177	+40%	+$2.39K	﹤0.01%	899
2026 Q1	$6.09K	Sell	440 -154	-26%	-$2.14K	﹤0.01%	943
2025 Q4	$8.34K	Sell	594 -179	-23%	-$2.51K	﹤0.01%	830
2025 Q3	$10.8K	Buy	773 +64	+9%	+$921	﹤0.01%	734
2025 Q2	$10.7K	Buy	709 +493	+228%	+$7.04K	﹤0.01%	635
2025 Q1	$2.85K	Buy	216 +40	+23%	+$552	﹤0.01%	813
2024 Q4	$2.78K	Buy	+176	New	+$2.64K	﹤0.01%	812

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Physician Wealth Advisors's RDY Position: Q2 2026 in Review

Physician Wealth Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 40% in Q2 2026, buying an estimated $2.39K and bringing the position to 617 shares worth $8.94K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

Physician Wealth Advisors first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.8K in Q3 2025. 68 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Physician Wealth Advisors held 617 shares of Dr. Reddy's Laboratories worth $8.94K as of Q2 2026.
Physician Wealth Advisors bought 177 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $2.39K.
Dr. Reddy's Laboratories made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #899 holding.
Physician Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
Physician Wealth Advisors's Dr. Reddy's Laboratories position peaked at $10.8K in Q3 2025.
68 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.